Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EIDX
2251
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $809K | ﹤0.01% |
14,100
+400
| +3% | +$19.8K |
|
2252
Beazer Homes USA
BZH
$874M
| $805K | ﹤0.01% |
57,000
-1,100
| -2% | -$16.7K |
|
|
AMK
2253
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $804K | ﹤0.01% |
+27,700
| New | +$725K |
|
|
CRC
2254
DELISTED
California Resources Corporation
CRC
| $804K | ﹤0.01% |
89,089
+3,100
| +4% | +$25.1K |
|
|
TUP
2255
DELISTED
Tupperware Brands Corporation
TUP
| $801K | ﹤0.01% |
93,300
+2,700
| +3% | +$29.4K |
|
|
VIVO
2256
DELISTED
Meridian Bioscience Inc
VIVO
| $799K | ﹤0.01% |
81,800
+2,800
| +4% | +$26.3K |
|
|
DX
2257
Dynex Capital
DX
$3.21B
| $798K | ﹤0.01% |
47,133
+1,000
| +2% | +$16.1K |
|
2258
Tilray
TLRY
$651M
| $797K | ﹤0.01% |
4,650
+180
| +4% | +$37.2K |
|
2259
Motorcar Parts of America
MPAA
$236M
| $796K | ﹤0.01% |
36,150
+1,700
| +5% | +$32.9K |
|
|
COWN
2260
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $796K | ﹤0.01% |
50,525
| – | – |
|
|
FBM
2261
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $795K | ﹤0.01% |
41,100
+800
| +2% | +$15.4K |
|
|
ACRE
2262
Ares Commercial Real Estate
ACRE
$262M
| $789K | ﹤0.01% |
49,800
+1,700
| +4% | +$26.4K |
|
|
PDS
2263
Precision Drilling
PDS
$1.07B
| $785K | ﹤0.01% |
28,210
+995
| +4% | +$22.8K |
|
2264
Q32 Bio
QTTB
$459M
| $785K | ﹤0.01% |
2,106
+95
| +5% | +$27.2K |
|
2265
Hackett Group
HCKT
$285M
| $784K | ﹤0.01% |
48,592
+1,200
| +3% | +$19.1K |
|
|
AMAG
2266
DELISTED
AMAG Pharmaceuticals
AMAG
| $784K | ﹤0.01% |
64,457
| – | – |
|
2267
McEwen Inc
MUX
$1.17B
| $780K | ﹤0.01% |
61,453
+7,420
| +14% | +$105K |
|
|
OLP
2268
One Liberty Properties
OLP
$515M
| $778K | ﹤0.01% |
28,600
+900
| +3% | +$24.7K |
|
|
SAFE
2269
DELISTED
Safehold Inc.
SAFE
| $778K | ﹤0.01% |
+19,300
| New | +$708K |
|
|
CUTR
2270
DELISTED
Cutera, Inc.
CUTR
| $777K | ﹤0.01% |
+21,700
| New | +$733K |
|
|
TRUE
2271
DELISTED
TrueCar
TRUE
| $772K | ﹤0.01% |
162,600
+7,700
| +5% | +$32.1K |
|
2272
Cato Corp
CATO
$65.3M
| $767K | ﹤0.01% |
44,100
+1,000
| +2% | +$17.9K |
|
2273
Century Aluminum
CENX
$5.18B
| $767K | ﹤0.01% |
102,050
+3,700
| +4% | +$25.6K |
|
2274
The RealReal
REAL
$1.44B
| $765K | ﹤0.01% |
+40,600
| New | +$777K |
|
2275
Precigen
PGEN
$2.46B
| $764K | ﹤0.01% |
139,700
+3,900
| +3% | +$22K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.